Some of Europe’s biggest pharmaceutical companies are asking the EU for a “one-time pass” on rules requiring medications to be labeled in over 20 European languages.
Drugmakers say it will help them to produce an eventual COVID-19 vaccine faster, bypassing a lengthy process of translating packaging and instructions.
Instead, one single language would be chosen for hundreds of millions of doses.
Consumer groups worry it could set a dangerous precedent and become a permament excuse for companies to cut corners on consumer protection.
Watch an interview with Monique Goyens, from the European Consumer Organisation in the player above.